Navigation Links
True/Fix Distal Femoral Nail System

ProductsTrue/Fix Distal Femoral Nail System
Company Encore Medical Corporation
Item True/Fix Distal Femoral Nail System
Features 
  • True/Fix Distal Femoral Nail System
  • Six distal locking screw options
  • Distal locking hole has 7.0mm cannulated screw option
  • Titanium flexibilty and biocompatibility
  • Distal 7.0mm OD shaft transfixing screw option
  • True/Fix 5.0mm self-tapping cortical screws
  • True/Fix Universal Targeting System
    • Description True/Fix Distal Femoral Nail System
    Info Encore Medical Corporation
    Customer Service: (800) 456-8696
    Web site: http://www.encoremed.com/

    Related medicine products :

    1. True/Fix Ankle Fusion Nail System
    2. True/Fix Cannulated Bone Screw System
    3. True/Fix Compression Hip Screw
    4. MIS Distal Femoral Alignment/Saw Guide and Intramedullary Rod
    5. Distal Femoral Nail
    6. Distal Radius Fixator (DRF)
    7. WristFixTM Distal Radius Fixation System
    8. Adjustable Distal Radius Fixator
    9. DFS Dimension Distal Radius Fixation System
    10. VG1 ALIF (Anterior) Femoral Trapezoid
    11. VG1 ALIF (Anterior Lateral) Femoral Trapezoid
    Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5MedicAlert Foundation International and CAP STS Collaborate to Standardize Emergency Medical Information 59051 1MedicAlert Foundation International and CAP STS Collaborate to Standardize Emergency Medical Information 59051 2MedicAlert Foundation International and CAP STS Collaborate to Standardize Emergency Medical Information 59051 3MedicAlert Foundation International and CAP STS Collaborate to Standardize Emergency Medical Information 59051 4Purolator USA Offers Advanced Tracking Capabilities for Medical Device Shipments 59046 1Purolator USA Offers Advanced Tracking Capabilities for Medical Device Shipments 59046 2Purolator USA Offers Advanced Tracking Capabilities for Medical Device Shipments 59046 3Free Pills from Government Boost Potassium Iodide Sales 59040 1Free Pills from Government Boost Potassium Iodide Sales 59040 2